Rise and shine. Another busy day is on the way. And there have been a lot of busy days recently, yes? Meetings and deadlines, deadlines and meetings. It never stops. To cope, we are brewing that mandatory cup of stimulation as we tackle our own version of R&D. Meanwhile, here are a few items of interest to help you along. We hope your day goes well and that you conquer the world.
J&J Names A New Public Relations Chief (Ad Age)
Merck CEO Defends R&D Spending (Reuters)
Thomas H Lee In Lead To Buy Glaxo Consumer Products (Bloomberg News)
NY Gov Signs Bills Limiting Mail-Order Pharmacies (Dow Jones)
Express Scripts And Wellpoint Fight Over NextRx Deal (Bloomberg News)
Qnexa Diet Pill Helped Keep Weight Down For Two Years: Study (Reuters)
Bristol-Myers Expand Research Deal With China's Simcere (Pharma Times)
Glaxo And University Team To Research Huntingdon's Disease (Reuters)
Specialist ECG Firms Preferred Over Big CROs: Survey (Outsourcing Pharma)
Glenmark And Nepo Pharma Go To Arbitration Over Collaboration (The Hindu)
EDITOR'S NOTE: Please check this post for updates throughout the morning
1 Comment
Thanks, Ed! Would love to know what is in or comes with your coffee...p.s. don't tell anyone about this, b/c I am not supposed to be typing...I am supposed to be resting my hand and arm...getting old is a pain...